Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Flortaucipir (18F) PET Imaging in the BIOCARD Study

Trial Profile

Flortaucipir (18F) PET Imaging in the BIOCARD Study

Discontinued
Phase of Trial: Phase I

Latest Information Update: 17 Dec 2018

At a glance

  • Drugs Flortaucipir-F-18 (Primary)
  • Indications Cognition disorders
  • Focus Diagnostic use
  • Sponsors Avid Radiopharmaceuticals
  • Most Recent Events

    • 07 Dec 2018 Status changed from recruiting to discontinued study terminated due to lower than expected enrollment
    • 01 Mar 2018 Planned End Date changed from 31 Jan 2018 to 31 Jan 2019.
    • 01 Mar 2018 Planned primary completion date changed from 31 Jan 2018 to 31 Jan 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top